UnitedHealth Group, Eli Lilly and Company, and Pfizer are the three Medical stocks to watch today, according to MarketBeat’s stock screener tool. Medical stocks are shares of publicly traded companies involved in the research, development, manufacturing and distribution of medical products and services—ranging from pharmaceuticals and biotechnology to medical devices and healthcare facilities. For investors, these equities offer exposure to the healthcare sector, with performance often driven by clinical trial results, regulatory approvals and patent lifecycles. They can be more volatile than broader market indices due to binary events (e.g., trial readouts, FDA decisions) but also present long-term growth potential from rising healthcare demand. These companies had the highest dollar trading volume of any Medical stocks within the last several days.
UnitedHealth Group (UNH)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Eli Lilly and Company (LLY)
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.
Read Our Latest Research Report on LLY
Pfizer (PFE)
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands.
Read Our Latest Research Report on PFE
Recommended Stories
- MarketBeat’s Top Five Stocks to Own in October 2025
- Cheap Chipotle? Why CMG Stock Could Be Ready for a Comeback
- 3 Industrial Stocks Ready to Benefit From Fed Cuts and Spending
- A Copper Catalyst: Why Freeport-McMoRan Is Positioned to Rebound
- MarketBeat Week in Review – 09/29 – 10/03
- After Trump Deal, Can Meta Stock Withstand TikTok’s Onslaught?